Jeff Isaacson
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 7
- PARP inhibition in cancer therapy 7
-
- Cancer therapeutics and mechanisms 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Jim Xiao (3 shared papers)Heidi Giordano (4 shared papers)Lindsey Rolfe (3 shared papers)Sandra Goble (2 shared papers)Susan M. Domchek (2 shared papers)Lara Maloney (2 shared papers)Patricia LoRusso (1 shared paper)Amit M. Oza (2 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Jeff Isaacson
8 papers receiving 277 citations
Peers
Comparison fields: 5 of 36
- Reproductive Medicine 83
- Oncology 242
- Physiology 11
- Immunology 42
- Molecular Biology 102
Countries citing papers authored by Jeff Isaacson
This map shows the geographic impact of Jeff Isaacson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Isaacson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Isaacson more than expected).
Fields of papers citing papers by Jeff Isaacson
This network shows the impact of papers produced by Jeff Isaacson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Isaacson. The network helps show where Jeff Isaacson may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Isaacson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 187 | |
| 2 | 2019 | 29 | |
| 3 | 2014 | 29 | |
| 4 | 2018 | 19 | |
| 5 | 2014 | 12 | |
| 6 | 2023 | 5 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 2 |
About Jeff Isaacson
Jeff Isaacson is a scholar working on Oncology, Molecular Biology, Genetics, Immunology and Plant Science, having authored 8 papers that have together received 286 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), Cancer therapeutics and mechanisms (1 paper), Cancer Genomics and Diagnostics (1 paper), CRISPR and Genetic Engineering (1 paper), Plant Virus Research Studies (1 paper), BRCA gene mutations in cancer (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Reproductive Medicine (83 citations), Oncology (242 citations), Physiology (11 citations), Immunology (42 citations) and Molecular Biology (102 citations). Jeff Isaacson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jim Xiao, Heidi Giordano, Lindsey Rolfe, Sandra Goble, Susan M. Domchek, Lara Maloney, Patricia LoRusso, Amit M. Oza, Manish R. Patel and Yvette Drew. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.